US Patent 11123344 Bupropion as a modulator of drug activity
Patent 11123344 was granted and assigned to Axsome Therapeutics on September, 2021 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
October 15, 2020
0
Date of Patent
September 21, 2021
0
Patent Application Number
20201015
0
Patent Citations Received
•••
Patent Inventor Names
Herriot Tabuteau
0
Patent Jurisdiction
Patent Number
Find more entities like US Patent 11123344 Bupropion as a modulator of drug activity
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
